# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001140361-24-001358
Filing Date
2024-01-08
Accepted
2024-01-08 17:14:56
Documents
38
Period of Report
2024-01-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | ef20018306_8k.htm iXBRL | 8-K | 30339
2 | EXHIBIT 99.1 | ef20018306_ex99-1.htm | EX-99.1 | 51139
6 |  | ef20018306_ex99-1slide1.jpg | GRAPHIC | 179459
7 |  | ef20018306_ex99-1slide2.jpg | GRAPHIC | 395904
8 |  | ef20018306_ex99-1slide3.jpg | GRAPHIC | 137657
9 |  | ef20018306_ex99-1slide4.jpg | GRAPHIC | 138087
10 |  | ef20018306_ex99-1slide5.jpg | GRAPHIC | 111317
11 |  | ef20018306_ex99-1slide6.jpg | GRAPHIC | 130346
12 |  | ef20018306_ex99-1slide7.jpg | GRAPHIC | 194744
13 |  | ef20018306_ex99-1slide8.jpg | GRAPHIC | 99101
14 |  | ef20018306_ex99-1slide9.jpg | GRAPHIC | 147455
15 |  | ef20018306_ex99-1slide10.jpg | GRAPHIC | 114860
16 |  | ef20018306_ex99-1slide11.jpg | GRAPHIC | 133416
17 |  | ef20018306_ex99-1slide12.jpg | GRAPHIC | 133163
18 |  | ef20018306_ex99-1slide13.jpg | GRAPHIC | 267518
19 |  | ef20018306_ex99-1slide14.jpg | GRAPHIC | 180096
20 |  | ef20018306_ex99-1slide15.jpg | GRAPHIC | 149849
21 |  | ef20018306_ex99-1slide16.jpg | GRAPHIC | 116921
22 |  | ef20018306_ex99-1slide17.jpg | GRAPHIC | 126596
23 |  | ef20018306_ex99-1slide18.jpg | GRAPHIC | 159148
24 |  | ef20018306_ex99-1slide19.jpg | GRAPHIC | 130544
25 |  | ef20018306_ex99-1slide20.jpg | GRAPHIC | 173978
26 |  | ef20018306_ex99-1slide21.jpg | GRAPHIC | 183749
27 |  | ef20018306_ex99-1slide23.jpg | GRAPHIC | 115961
28 |  | ef20018306_ex99-1slide24.jpg | GRAPHIC | 189406
29 |  | ef20018306_ex99-1slide25.jpg | GRAPHIC | 113025
30 |  | image00001.jpg | GRAPHIC | 137996
| Complete submission text file | 0001140361-24-001358.txt |  | 5688024

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | bbio-20240108.xsd | EX-101.SCH | 3869
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | bbio-20240108_lab.xml | EX-101.LAB | 22547
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | bbio-20240108_pre.xml | EX-101.PRE | 16047
32 | EXTRACTED XBRL INSTANCE DOCUMENT | ef20018306_8k_htm.xml | XML | 4224

Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38959 | Film No.: 24521033
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)